https://www.forex-news.com/
Forex-News has been the world leading economy news website since 2005. It has been a joyful path full of changing variables in this changing world. During the last three years we have also covered some of the most important news regarding Bitcoin and other cryptocurrencies. Wherever the news are, we are there.
, ROUNDUP / New York Stocks Conclusion: Dow recovers 30,000 points | message, Forex-News, Forex-News
Bitcoin
$55,693.49
+147.27
Ethereum
$2,171.66
-0.54
Litecoin
$266.44
+1.91
DigitalCash
$294.94
-3.75
Monero
$354.49
+36.02
Nxt
$0.08
0
Ethereum Classic
$35.28
-3.12
Dogecoin
$0.40
+0.07

ROUNDUP / New York Stocks Conclusion: Dow recovers 30,000 points | message

1
, ROUNDUP / New York Stocks Conclusion: Dow recovers 30,000 points | message, Forex-News, Forex-News


, ROUNDUP / New York Stocks Conclusion: Dow recovers 30,000 points | message, Forex-News, Forex-News

NEW YORK (dpa-AFX) – Investors on Wall Street honored the progress made in talks about another US aid package and the start of corona vaccination across the country on Tuesday. The Dow Jones Industrial (Dow Jones 30 Industrial) surpassed the highly regarded mark of 30,000 points and closed 1.13 percent up with 30 199.31 points. The day before, the leading US index had reached a record high of 30,325 points, but then fell back.

The market-wide S&P 500 advanced 1.29 percent on Tuesday to 3694.62 points. For the technology-heavy NASDAQ 100 it went up 1.07 percent to 12,595.92 points.

After an emergency approval, vaccinations against Covid-19 began in all US states on Monday. First of all, employees of health facilities as well as residents of old people’s and nursing homes are to be vaccinated. It is the largest vaccination campaign in the country’s history.

Investors are also hoping for the long-announced government aid package for the economy that has been hard hit by the corona pandemic. In addition, the US Federal Reserve will announce its monetary policy decisions on Wednesday.

Among the individual stocks in the Dow, the shares of Apple stood out positively with a whopping price increase of 5.0 percent. As the Japanese business newspaper “Nikkei” reports, the group wants to increase its iPhone production in the first half of 2021 by 30 percent. The plan is to manufacture up to 96 million devices. In particular, the demand for the new iPhone 12 model is apparently very high.

Prevail Therapeutics’ shares shot up 82 percent to $ 22.75 after US pharmaceuticals company Eli Lilly (Eli Lilly and) announced it would take over the biotech company. Prevail shareholders are to receive $ 22.50 per share in cash, which corresponds to a premium of 80 percent on the closing price on Monday. Eli Lilly’s papers rose around 6 percent.

Shortly before a possible emergency approval, the US Food and Drug Administration (FDA) presented figures on the high effectiveness of Moderna’s corona vaccine. Media reported that the emergency vaccine approval was likely on Friday. Moderna shares continued their correction after the price jump at the end of November and fell 5.1 percent on Tuesday.

Bristol-Meyers Squibb (BMS) (Bristol-Myers Squibb) papers benefited from a positive analyst study, gaining 4.3 percent. Goldman Sachs had made positive comments about the pharmaceutical stock and put it on the “Conviction Buy List” for particularly promising stocks.

The rate of the euro hardly moved in US trading. The common currency last cost 1.2160 US dollars. The European Central Bank (ECB) had set the reference rate at 1.2140 (Monday: 1.2162) dollars. The dollar had thus cost 0.8237 (0.8222) euros.

US Treasuries fell. The futures contract for ten-year Treasuries (T-Note-Future) recently traded 0.07 percent lower at 137.98 points. The yield on the ten-year bond was 0.91 percent./edh/mis



, ROUNDUP / New York Stocks Conclusion: Dow recovers 30,000 points | message, Forex-News, Forex-News

Get real time updates directly on you device, subscribe now.

, ROUNDUP / New York Stocks Conclusion: Dow recovers 30,000 points | message, Forex-News, Forex-News

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More